Gartner Blog Network

2014 Life Science Hype Cycle has published

by Michael Shanler  |  August 5, 2014  |  Comments Off on 2014 Life Science Hype Cycle has published

Fifty technologies are profiled by Gartner analysts in this year’s Hype Cycle for Life Sciences, 2014.    This is the most densely packed hype cycle since the LS HC  introduction in 2003.   This year, we added 8 new profiles and renamed a few others (with justification) to reflect the latest technology evolution.  The sheer volume of profiles reiterate that IT and technology are becoming more pervasive and are redefining the boundaries of this industry.  Some of these new technologies are in the tech “trigger” phase.   A handful of others were added, reflecting our expanded area of coverage (and some tenacious prodding by clients.)

My last blog post was centered on the “digital transformation” required by the industry as a whole.  While the message for the next few years is surely “digital”, there are a lot of questions about how and when to make investments in technology.  The move to digital will require both cutting edge and mature technologies.   As a reminder, just because a technology might be on the upswing “trigger” on our curve, it does not automatically mean that you must make the investment.  Likewise, technologies in the “trough” don’t automatically mean that it is not the right answer for your organization’s challenge.    You can find a refresher on how to interpret a hype cycle in these documents using these links:

The  information in this life science hype cycle is useful for business and IT leaders that are leading the digital transformation at pharma, biotech, CRO, CMOs and medical device companies.   This includes early stage research, clinical development, quality, legal, manufacturing, supply chain, ops, med affairs, regulatory, sales, and marketing organizations.

Additional Resources

Predicts 2019: Data and Analytics Strategy

Data and analytics are the key accelerants of digitalization, transformation and “ContinuousNext” efforts. As a result, data and analytics leaders will be counted upon to affect corporate strategy and value, change management, business ethics, and execution performance.

Read Free Gartner Research

Category: 3d-printing  additive-manufacturing  analytics  clinical-development  ctms  data-and-analytics-strategies  eclinical  edc  engineering  epro  gartner  innovation  internet-of-everything  internet-of-things  iot  it  manufacturing  nexus-of-forces  nof  pharmaceutical  product-development  rd  science  wearables  

Tags: 3d-printing  3dp  3dprinting  additive-manufacturing  big-data  bigdata  collaboration  digital  eln  engineering-2  informatics  innovation  iot  it  life-science  lims  nexus  pharma  plm  product-development-2  prototyping  rd  science-2  

Michael Shanler
Research VP
5 years at Gartner

Michael Shanler covers life science R&D technologies. Read Full Bio

Comments are closed

Comments or opinions expressed on this blog are those of the individual contributors only, and do not necessarily represent the views of Gartner, Inc. or its management. Readers may copy and redistribute blog postings on other blogs, or otherwise for private, non-commercial or journalistic purposes, with attribution to Gartner. This content may not be used for any other purposes in any other formats or media. The content on this blog is provided on an "as-is" basis. Gartner shall not be liable for any damages whatsoever arising out of the content or use of this blog.